Skip to main content
. Author manuscript; available in PMC: 2008 Nov 1.
Published in final edited form as: Neurotoxicology. 2007 Aug 24;28(6):1047–1067. doi: 10.1016/j.neuro.2007.08.007

Table 6.

PBDE levels in maternal and fetal blood

Country Year N Maternal blood Fetal blood Most prominent BDE congener Reference
U.S.A. 1997–99 50 <10–511 (10) ND * Petreas et al. 2003
U.S.A. 1999–01 24 5.3–320 (21) ND BDE-47 Bradman et al. 2007
U.S.A. 2001 15 15–580 (580) 14–460 (39) BDE-47 Mazdai et al. 2003
Sweden 2000–01 15 0.71–8.39 (2.07) 0.46–4.28 (1.69) BDE-47 Meironyte Guvenius et al. 2003
France 2005 26 0.21–1.91 (0.69) 0.14–1.08 (0.41) ** Antignac et al. 2006
Japan ND 89 0.74–21.19 (2.99) ND BDE-209 Inoue et al. 2006
China ND 21 1.6–17 (4.4) 1.5–12 (3.9) BDE-47
BDE-153 (fetus)
Bi et al. 2006

Values of ΣPBDE levels are expressed as ng/g lipid. Results indicate range and median (in parenthesis).

*

BDE-47 only;

**

BDE-153 only. ND = not determined.